Outcome of Therapies for Membranous Glomerulonephritis During Three Waves of COVID Pandemic

There is lack of clarity on immunosuppressive therapy in glomerular diseases and concomitant corona-virus infection. We retrospectively evaluated 36 patients with primary membranous nephropathy from January 2020 to December 2021 who had received immunosuppression during this period. Diagnosis of COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Asheesh, Singh, Ram, Chauhan, Ashish, Sharma, Dheeraj, Sandal, Rajeev, Chauhan, Naresh, Gupta, Samriti, Verma, Balbir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503582/
https://www.ncbi.nlm.nih.gov/pubmed/37781551
http://dx.doi.org/10.4103/ijn.ijn_162_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503582/
https://www.ncbi.nlm.nih.gov/pubmed/37781551
http://dx.doi.org/10.4103/ijn.ijn_162_22

Ejemplares similares